The original success of Viagra undeniably reshaped the pharmaceutical landscape, but betting in companies heavily reliant on off-patent versions presents a complex picture. Despite early profits were substantial, the end of patents and the rise of cheaper alternatives have diminished market share. Thus, a thorough evaluation of present financial pe